Marszałek A, Kubicka A, Jagiełło I, Malicka-Durczak A (2023) Potential impact of herceptest™ mab pharmdx (Dako Omnis) (Ge001) in breast cancer diagnosis. Pol J Pathol 74(2):82–88. https://doi.org/10.5114/pjp.2023.129352

Article  PubMed  Google Scholar 

Wang Y, Shen J, Gu P, Wang Z (2023) Recent advances progress in radiotherapy for breast cancer after breast-conserving surgery: a review. Front Oncol 13:1195266. https://doi.org/10.3389/fonc.2023.1195266

Wilkinson L, Gathani T (2022) Understanding breast cancer as a global health concern. Br J Radiol 95(1130):20211033. https://doi.org/10.1259/bjr.20211033

Sarhangi N, Hajjari S, Heydari SF, Ganjizadeh M, Rouhollah F, Hasanzad M (2022) Breast cancer in the era of precision medicine. Mol Biol Rep 49(10):10023–10037. https://doi.org/10.1007/s11033-022-07571-2

Article  PubMed  CAS  Google Scholar 

Ma M, Liu R, Wen C, Xu W, Xu Z, Wang S, Wu J, Pan D, Zheng B, Qin G, Chen W (2021) Predicting the molecular subtype of breast cancer and identifying interpretable imaging features using machine learning algorithms. Eur Radiol 32(3):1652–1662. https://doi.org/10.1007/s00330-021-08271-4

Article  PubMed  CAS  Google Scholar 

Yin L, Duan J-J, Bian X-W, Yu S-c (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 22(1):61. https://doi.org/10.1186/s13058-020-01296-5

Yang T, Yu R, Cheng C, Huo J, Gong Z, Cao H, Hu Y, Dai B, Zhang Y (2023) Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR. J Transl Med 21(1):597. https://doi.org/10.1186/s12967-023-04483-y

Fisusi FA, Akala EO (2019) Drug Combinations in breast cancer therapy. Pharm Nanotechnol 7(1):3–23. https://doi.org/10.2174/2211738507666190122111224

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang Y, Minden A (2022) Current molecular combination therapies used for the treatment of breast cancer. Int J Mol Sci 23(19):11046. https://doi.org/10.3390/ijms231911046

Liang Y, Zhang H, Song X, Yang Q (2020) Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. Semin Cancer Biol 60:14–27. https://doi.org/10.1016/j.semcancer.2019.08.012

Article  PubMed  CAS  Google Scholar 

Kim MY (2021) Breast cancer metastasis. Adv Exp Med Biol 1187:183–204. https://doi.org/10.1007/978-981-32-9620-6_9

Article  PubMed  CAS  Google Scholar 

Tan C, Han LI, Zou L, Luo C, Liu A, Sheng X, Xi DEE (2015) Expression of P2X7R in breast cancer tissue and the induction of apoptosis by the gene-specific shRNA in MCF-7 cells. Exp Ther Med 10(4):1472–1478. https://doi.org/10.3892/etm.2015.2705

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao Y, Li Z, Chen Y, Li Y, Lu J (2023) Suppression of P2X7R by local treatment alleviates acute gouty inflammation. J Inflamm Res 16:3581–3591. https://doi.org/10.2147/jir.S421548

Article  PubMed  PubMed Central  CAS  Google Scholar 

Qiao C, Tang Y, Li Q, Zhu X, Peng X, Zhao R (2022) ATP-gated P2X7 receptor as a potential target for prostate cancer. Hum Cell 35(5):1346–1354. https://doi.org/10.1007/s13577-022-00729-x

Article  PubMed  CAS  Google Scholar 

Wang Y, Chen S, Wang W, Chen J, Kong W, Wang Y (2021) Role of P2X7R in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps. Mol Med Rep 24(1):521. https://doi.org/10.3892/mmr.2021.12160

Abbracchio MP, Burnstock G, Boeynaems J-M, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International union of pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58(3):281–341. https://doi.org/10.1124/pr.58.3.3

Article  PubMed  CAS  Google Scholar 

Bin Dayel AF, Alonazi AS, Alshammari TK, Alrasheed NM (2023) P2X7 purinergic receptor: a potential target in heart diseases (Review). Mol Med Rep 27(3):74. https://doi.org/10.3892/mmr.2023.12961

Burnstock G, Knight GE (2017) The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression. Purinergic Signal 14(1):1–18. https://doi.org/10.1007/s11302-017-9593-0

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang W-j, Hu C-g, Zhu Z-m, Luo H-l (2020) Effect of P2X7 receptor on tumorigenesis and its pharmacological properties. Biomed Pharmacother 125:109844. https://doi.org/10.1016/j.biopha.2020.109844

Li Z, Huang Z, Bai L (2021) The P2X7 Receptor in osteoarthritis. Front Cell Dev Biol 9:628330. https://doi.org/10.3389/fcell.2021.628330

Scarpellino G, Genova T, Munaron L (2019) Purinergic P2X7 receptor: a cation channel sensitive to tumor microenvironment. Recent Pat Anti-Cancer Drug Discovery 14(1):32–38. https://doi.org/10.2174/1574892814666190116122256

Article  PubMed  CAS  Google Scholar 

Vultaggio-Poma V, Sarti AC, Di Virgilio F (2020) Extracellular ATP: a feasible target for cancer therapy. Cells 9(11):2496. https://doi.org/10.3390/cells9112496

Chen Y-H, Lin R-R, Tao Q-Q (2021) The role of P2X7R in neuroinflammation and implications in Alzheimer's disease. Life Sci 271:119187. https://doi.org/10.1016/j.lfs.2021.119187

Zheng L, Zhang X, Yang F, Zhu J, Zhou P, Yu F, Hou L, Xiao L, He Q, Wang B (2014) Regulation of the P2X7R by microRNA-216b in human breast cancer. Biochem Biophys Res Commun 452(1):197–204. https://doi.org/10.1016/j.bbrc.2014.07.101

Article  PubMed  CAS  Google Scholar 

Di Virgilio F, Dal Ben D, Sarti AC, Giuliani AL, Falzoni S (2017) The P2X7 receptor in infection and inflammation. Immunity 47(1):15–31. https://doi.org/10.1016/j.immuni.2017.06.020

Article  PubMed  CAS  Google Scholar 

Rotondo JC, Mazziotta C, Lanzillotti C, Stefani C, Badiale G, Campione G, Martini F, Tognon M (2022) The role of purinergic P2X7 receptor in inflammation and cancer: novel molecular insights and clinical applications. Cancers 14(5):1116. https://doi.org/10.3390/cancers14051116

Tang Y, Qiao C, Li Q, Zhu X, Zhao R, Peng X (2022) Research progress in the relationship between P2X7R and cervical cancer. Reprod Sci 30(3):823–834. https://doi.org/10.1007/s43032-022-01022-w

Article  PubMed  CAS  Google Scholar 

Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18(10):601–618. https://doi.org/10.1038/s41568-018-0037-0

Article  PubMed  CAS  Google Scholar 

Wang Y, Shan Z, Zhang L, Fan S, Zhou Y, Hu L, Wang Y, Li W, Xiao Z (2022) P2X7R/NLRP3 signaling pathway-mediated pyroptosis and neuroinflammation contributed to cognitive impairment in a mouse model of migraine. J Headache Pain 23(1):75. https://doi.org/10.1186/s10194-022-01442-8

Adinolfi E, Giuliani AL, De Marchi E, Pegoraro A, Orioli E, Di Virgilio F (2018) The P2X7 receptor: A main player in inflammation. Biochem Pharmacol 151:234–244. https://doi.org/10.1016/j.bcp.2017.12.021

Article  PubMed  CAS  Google Scholar 

El Idrissi IG, Podlewska S, Abate C, Bojarski AJ, Lacivita E, Leopoldo M (2024) Structure-activity relationships and therapeutic potential of purinergic P2X7 receptor antagonists. Curr Med Chem 31(11):1361–1403. https://doi.org/10.2174/0929867330666230403094538

Xiao W, Gong C, Liu X, Liu Y, Peng S, Luo D, Wang R, Li T, Zhao J, Xiong C, Liang S, Xu H (2019) Association ofP2X7Rgene with serum lipid profiles in Chinese postmenopausal women with osteoporosis. Climacteric 22(5):498–506. https://doi.org/10.1080/13697137.2019.1604654

Article  PubMed  CAS  Google Scholar 

Arulkumaran N, Unwin RJ, Tam FWK (2011) A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 20(7):897–915. https://doi.org/10.1517/13543784.2011.578068

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang Z-F, Wu W, Hu H-B, Li Z-Y, Zhong M, Zhang L (2022) P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption. World J Gastroenterol 28(36):5265–5279. https://doi.org/10.3748/wjg.v28.i36.5265

Article  PubMed  PubMed Central  CAS  Google Scholar 

Di Virgilio F, Jiang L-H, Roger S, Falzoni S, Sarti AC, Vultaggio-PomaV CP, Adinolfi E (2019) Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells. Methods Enzymol 629:115–150. https://doi.org/10.1016/bs.mie.2019.07.043

Article  PubMed  CAS  Google Scholar 

Zhang R, Su K, Yang L, Tang M, Zhao M, Ye N, Cai X, Jiang X, Li N, Peng J, Zhang X, Wang B, Wu W, Ma L, Ye H (2023) Design, synthesis, and biological evaluation of novel P2X7 receptor antagonists for the treatment of septic acute kidney injury. J Med Chem 66(16):11365–11389. https://doi.org/10.1021/acs.jmedchem.3c00837

Article  PubMed  CAS  Google Scholar 

Cai X, Yao Y, Teng F, Li Y, Wu L, Yan W, Lin N (2021) The role of P2X7 receptor in infection and metabolism: based on inflammation and immunity. Int Immunopharmacol 101(Pt A):108297. https://doi.org/10.1016/j.intimp.2021.108297

Di Virgilio F, Giuliani AL (2016) Purinergic signalling in autoimmunity: a role for the P2X7R in systemic lupus erythematosus? Biom J 39(5):326–338. https://doi.org/10.1016/j.bj.2016.08.006